Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 13/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.40 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.40 |
| ▸ | TDP2 | O95551 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709019 | 1.00 | PGR (0.49) | PGRPDK2KDM4EALDH1A1GAA | |
| SCHEMBL30709050 | 0.90 | PGR (0.51) | PGRPDK2AR | |
| SCHEMBL15763534 | 0.87 | PGR (0.46) | PGRPDK2KDM4EALDH1A1GAA | |
| SCHEMBL18914750 | 0.85 | PGR (0.53) | PGRPDK2AR | |
| SCHEMBL26506713 | 0.84 | PDK2 (0.51) | PGRPDK2 | |
| SCHEMBL22106386 | 0.84 | PDK2 (0.42) | PDK2 | |
| SCHEMBL30553110 | 0.83 | PGR (0.42) | PGRPDK2 | |
| SCHEMBL27193175 | 0.83 | PGR (0.42) | PGRPDK2 | |
| SCHEMBL21922497 | 0.82 | PDK2 (0.39) | PGRPDK2AR | |
| SCHEMBL24570201 | 0.82 | PGR (0.60) | PGRPDK2TDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903548-A | Compound, composition for organic electroluminescent device, and display device | SK株式会社 | 2023-10-20 | — | — | CN | disclosed |
| US-9818951-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-9818951-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2017-11-14 | — | — | US | disclosed |
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-9484539-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2016-11-01 | — | — | US | disclosed |
| US-9484539-B2 | Polycyclic compound and organic electronic device comprising the same | LG CHEM, LTD. (KR) | 2016-11-01 | — | — | US | disclosed |
| EP-2876104-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2015-05-27 | — | — | EP | disclosed |
| US-20140151670-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2014-06-05 | — | — | US | disclosed |
| US-20140151670-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2014-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160329500-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | PIEZO1, EED, ETV6 | PGR 603/4885PDK2 2576/4885KDM4E 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.